MMMasashi Muraoka

Masashi Muraoka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Masashi Muraoka has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Tadayuki Oka

    Division of Surgical Oncology, Department of Translational Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    6 shared publications
  • Tsutomu Tagawa

    Division of Surgical Oncology, Department of Translational Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    4 shared publications
  • Akihiro Nakamura

    Division of Surgical Oncology, Department of Translational Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    3 shared publications
  • Hiroharu Tsuji

    3 shared publications
  • Hiroyoshi Ayabe

    3 shared publications
  • Katsunobu Kawahara

    3 shared publications

Latest Publications

  • Open Access

    Resection of liposarcoma of the greater omentum: A case report and literature review

    by Shintaro Hashimoto, Junichi Arai, Masato Nishimuta, Hirofumi Matsumoto, Hidetoshi Fukuoka, Masashi Muraoka, Masahiro Nakashima, Hiroyuki Yamaguchi

    Liposarcoma usually occurs in the retroperitoneum and limbs. Liposarcoma of the greater omentum is rare, and most information of such liposarcomas has come from case reports. A 60-year-old woman was found to have an 8-cm intra-abdominal mass (suspected lipoma) by computed tomography. At the age of 63 years, she underwent a medical examination and a mass was palpated in the abdomen. Contrast-enhanced computed tomography and magnetic resonance imaging confirmed the presence of a huge intra-abdominal tumor with the omental artery passing through the mass. The tumor was simply resected. Histopathologically, the tumor was diagnosed as a well-differentiated liposarcoma, and the resection margin was microscopically negative. The patient had developed no recurrence or complications 9 months postoperatively. Liposarcoma of the greater omentum is rare, and differentiation of liposarcoma from other tumors is challenging. Adjuvant therapy has not been established as an effective treatment, and radical (R0) resection of the tumor is recommended. Our case of liposarcoma of the greater omentum was surgically managed with good outcomes. The diagnosis of liposarcoma with a lipomatous tumor is challenging, and resection should be considered for huge intra-abdominal lipomatous tumors.


  • Open Access

    Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer

    by Masashi Muraoka, Shinji Akamine, Tadayuki Oka, Tsutomu Tagawa, Akihiro Nakamura, Tomoshi Tsuchiya, Tomayoshi Hayashi, Takeshi Nagayasu

    Objective: It is controversial whether a systematic mediastinal lymph node dissection (MLND) needs to be performed in all patients with stage I lung cancer. The present study was done to examine the new sentinel lymph nodes hypothesis based on the lobe of the primary tumor. Methods: In our first study, the lymph node (LN) metastases were assessed in 291 stage I non-small cell lung cancer (NSCLC) patients who had a major lung resection with a systematic mediastinal lymph node dissection. We evaluated the validity of using our new sentinel lymph nodes method based on the lobe of the primary tumor as follows: the pretracheal (#3), tracheobronchial (#4), and hilar nodes (#10) for right upper lobe tumors; #4, subcarinal (#7), and #10 for middle lobe tumors; the subaortic (#5), paraaortic (#6), and #10 for left upper lobe tumors; and the #7, #10, and interlobar nodes (#11) for tumors in either lower lobes. In the second study, we performed a lobectomy with new sentinel node sampling in 64 patients with preoperative complications. If all of the sampling nodes showed no metastases on frozen section diagnosis, systematic node dissections were not performed. Results: Six of 291 patients in the first study had skip metastases that did not involve the new sentinel nodes; 5 of the 6 patients had macroscopic pleural invasion. Thus, we defined pleural invasion as an exclusion criterion for the second study. In the second study, the median follow-up time was 39 months. Metastatic lymph nodes were detected in 11 of 64 patients. Fifty-three patients (83%) had no metastasis in the sampled nodes, and, therefore, a mediastinal lymph node dissection was not done. The morbidity rate in the sampling group was 36%, and there was no mortality. In the sampling group, local recurrences were observed in two patients, distant metastases in eight, and carcinomatous pleuritis in one; the overall 5-year survival rate was 82%. Conclusions: We found that it is possible to perform a less invasive lymphadenectomy for patients with stage I lung cancer using intra-operative sampling of new sentinel lymph nodes.


  • Open Access

    Surgical Treatment for Multiple Primary Lung Cancer

    by Masashi Muraoka, Tadayuki Oka, Shinji Akamine, Tsutomu Tagawa, Satoshi Hashizume, Keitaro Matsumoto, Yutaka Tagawa, Tomayoshi Hayashi, Takeshi Nagayasu

    目的. 多発肺癌に対する外科治療成績を検討し, 手術適応と術式選択につき検討する. 対象と方法. 臨床病理学的に多発肺癌と診断した64例を対象とした. 結果. 平均年齢64.3歳, 男女比49:15, 同時性27, 異時性37例. 組織型は共に腺癌27, 共に扁平上皮癌14, 腺癌―扁平上皮癌11例で, 病期は共にI期35, I・II期14例. 同時性では一期的手術14例, 二期的手術11例で, 複数回手術43例の初回手術は肺葉切除 (27例) が多く, 2回目は縮小手術が多かった (28例). 4例に両側肺葉切除, 3例に残存肺全摘術を行った. 術死および重篤な術後合併症は認めなかった. 予後は異時性が術後5年生存率 (5生率) 74.9%, 同時性は63.9%であった. 異時性で二次癌がIA期では5生率85.1%, IB期で66.7%, II期以上は有意に予後不良であった. 組織型では共に腺癌 (81.5%) が最も良好であった. 結論. 多発肺癌に対する外科治療は合併症も少なく安全に施行できた. 二次癌に対しても, 残存肺機能やperformance statusがよい症例には, 両側肺葉切除や残存肺全摘術も可能である. 特にI期症例では予後も期待でき, 積極的に外科治療を行うべきである.


  • Open Access

    Thoracoscopic drainage with wound edge protector for descending necrotizing mediastinitis

    by Takeshi Nagayasu, Shinji Akamine, Tadayuki Oka, Masashi Muraoka

    It has recently been found that wide recognition of descending necrotizing mediastinitis (DNM) and its resultant early diagnosis can reduce the high mortality rate associated with this disease by allowing for rapid surgical intervention. Nevertheless, thoracotomy remains controversial as a treatment for DNM. We report a successful case of DNM in which the mediastinitis had spread below the carina and which was treated by drainage through cervicotomy and by thoracoscopic drainage with mini-thoracotomy using the newly available wound edge protector called a Lap-protector.


  • A CASE OF RADIATION-INDUCED LEIOMYOSARCOMA IN THE CHEAT WALL

    by Norio Yamaoka, Yoshitaka Uchiyama, Akihiro Nakamura, Masashi Muraoka, Masamichi Kondou, Hideto Yamauchi, Hiroshi Hashiyada, Koji Hashizume

  • Argyrophilic Nucleolar Organizer Regions and Degree of Malignancy in Adenocarcinomas of The Lung Less Than 2.0cm in Size.

    by Norio Yamaoka, Yoshitaka Uchiyama, Tadayuki Oka, Hideki Taniguchi, Masashi Muraoka, Isao Sano, Kouichi Tuji

  • The Results of Tracheobronchoplasty for Hilar Type Early Lung Cancer.

    by Hiroyoshi Ayabe, Masashi Muraoka, Akihiro Nakamura, Tsutomu Tagawa, Noriaki Itoyanagi, Hiroharu Tsuji, Shinsuke Hara, Yutaka Tagawa, Katsunobu Kawahara, Masao Tomita

    肺門型早期扁平上皮癌11例の外科治療成績について報告した. 男性10例, 女性1例で平均年齢は63.5才 (55~68) であった. 肺癌の発見動機は検診6例, 他疾患経過中1例, 血疾等の呼吸器症状4例であった. 全例扁平上皮癌である. 11例中1例では主気管支, 左右の区域支の3ヵ所の同時性多発早期癌であった. 手術々式は気管分岐部切除2例, 気管支形成1例, 肺葉切除+気管支形成3例, 区域切除+気管支形成2例, 肺葉切除2例, 右主気管支形成, 右S9+10, 左S1+2+3の区域切除1例であった. 5例 (45%) に術後合併症をみたが, 手術死, 入院死亡例はなかった. 11例中7例が術後2, 3, 4, 19, 39, 48, 50ヵ月再発なく生存中であるが, 4例が術後13, 18, 36, 147ヵ月後各々呼吸不全, 悪性リンパ腫, 多発肺癌, 脳梗塞にて死亡した.肺門型早期扁平上癌例では気管・気管支形成術を併用し可及的に肺機能の温存をはかった術式を選択するべきである.

  • Bronchogenic cyst in the posterior mediastinum; a case report.

    by Hiroharu Tsuji, Tadayuki Oka, Shinsuke Hara, Hiroyuki Kusano, Tsutomu Tagawa, Akiriro Nakamura, Masafumi Rorinaga, Masashi Muraoka, Satoshi Yamamoto, Yasushi Tagawa, et al.

    縦隔発生の気管支性嚢腫のうち後縦隔発生のものは希で左横隔膜直上, 下行大動脈外側に発生した症例を報告した.症例は32歳男性, 検診にて左下肺野, 心陰影に重なる径6cmの辺縁平滑な腫瘤陰影を指摘された. CTでは横隔膜直上後縦隔部の腫瘤は境界鮮明で内部構造均一で CT値は37.4であり, MRIではT2強調画像で高信号として認められた.後縦隔腫瘍, 特にその発生部位から神経原性腫瘍の術前診断で腫瘍摘出術を施行した.腫瘍は6.5×5.5×3.5cm, 重量119gであり約40m1の白色混濁液を容れる単房生嚢腫であった.病理組織標本では, 嚢腫内面は繊毛円柱上皮ないし重層扁平上皮でおおわれ, 壁は気管支軟骨類似の軟骨と気管支腺類似の腺管がみとめられ本症と診断された.また内*液のCEA 値は2977.7ng/mlと高値を呈した.

  • Open Access

    A CASE REPORT OF ADENOACANTHOMA OF THE INTRA-THORACHIC ESOPHAGUS

    by Hironobu Toochika, Masashi Muraoka, Hiroharu Tsuji, Tadayuki Oka, Shinsuke Hara, Chia-Ming Hsieh, Kouji Kimino, Hiroyuki Kusano, Yutaka Tagawa, Katsunobu Kawahara, et al.

    A 46-years-old man visited with the chief complaint of back pain and dysphagia. Upper gastrointestinal series and gastrointestinal fiberscope revealed a primary adenocarcinoma of the esophagus. Then he addmited to our hospital for the operation. Upper gastrointestinal series showed the tumor which was 11cm in size, circular type and well defined margine at the site of the middle esophagus. Chest tomography and computed tomography revealed a cancer invaded the left main bronchus and the wall of dessending aorta. The left thoracotomy was performed. The tumor was removed from the left main bronchus as much as possible. the dessending aorta was simultaneously resected with the esophagus by 11cm of length, and replaced with the graft. Cervical esophagocutaneostomy was made. The surgical disease staging was A3N3M0Pl0 and Staghe IV. Macroscopically, the tumor mass was 8.5×4.0cm in size with well defined marging and prominent type, and involved the aorta. Microscopically, the tumor was moderately differenciated adenocarcinoma with a part of squamous cell carcinoma pattern. The pathological diagnosis was adenoacanthoma, IFNγ, ie(+), ly(+) and v(+), involving the outward wall of the aorta. Six months after operation, he died of the recurrence and the autopsy was made.